{
    "nctId": "NCT03447886",
    "briefTitle": "Understanding Barriers to Initiation and Adherence to Endocrine Therapy in Young Breast Cancer Survivors of Diverse Backgrounds",
    "officialTitle": "Understanding Barriers to Initiation and Adherence to Adjuvant Endocrine Therapy in Young Breast Cancer Survivors of Diverse Racial, Ethnic, and Socio-economic Backgrounds: The EMPOWER Study",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 17,
    "primaryOutcomeMeasure": "Decision-making around endocrine therapy in young women with HR+ breast cancer.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Are Hispanic, Latina, Black, or identify as socio-economically disadvantaged (any racial/ethnic background) as measured by an item of financial distress answering that they are \"having difficulty paying the bills no matter what they do\" to a question about their current household financial situation.18, 19\n* report a history of Stage 1-3 breast cancer\n* reports HR+ breast cancer and confirm that they have had a discussion with their doctor about adjuvant ET; OR indicate that they are taking ET, even if they do not know their HR status, answer they are HR-, or do not recall having a discussion about ET)\n* not in active treatment (e.g., chemotherapy, radiation), with the exception of Herceptin\n* at least 3 months, but no more than 3 years out of completion of active treatment\n* no evidence of recurrent/metastatic disease\n* at least 18, but\\< 45 years of age at diagnosis of first invasive breast cancer\n* English or Spanish speaking\n* are willing to consent to the interview\n\nExclusion Criteria:\n\n* HR- breast cancer and indicate they are not taking ET\n* HR+ breast cancer but do not confirm discussion of ET or indicate they are taking ET\n* Stage 0 (DCIS) breast cancer\n* Recurrent or metastatic disease\n* Less than 3 months or more than 3 years post-active treatment\n* Less than 18 years old or \u226545 years old at diagnosis",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT"
}